Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Xin Fu

Showing results (201-210 of 337) with videos related to

Pageof 34
Sort By:
Nature Communications|July 21, 2019
NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistanceXiaoguang Li, Zhida Liu, Anli Zhang, et al.
Nature Immunology|July 31, 2012
OX40 signaling favors the induction of T(H)9 cells and airway inflammationXiang Xiao, Savithri Balasubramanian, Wentao Liu, et al.
Cancer Research|October 22, 2020
RIG-I-Like Receptor LGP2 Is Required for Tumor Control by RadiotherapyWenxin Zheng, Diana Rose E Ranoa, Xiaona Huang, et al.
Science Immunology|May 16, 2025
ILC3s promote intestinal tuft cell hyperplasia and anthelmintic immunity through RANK signalingHongkai Xu, Yibo Wang, Wenyan Wang, et al.
Cancer Cell|July 4, 2020
Telomere Stress Potentiates STING-Dependent Anti-tumor ImmunityIlgen Mender, Anli Zhang, Zhenhua Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastasesPing Yu, Youjin Lee, Yang Wang, et al.
The Journal of Experimental Medicine|March 7, 2020
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signalingYaoyao Shi, Wenxin Zheng, Kaiting Yang, et al.
Nature Cell Biology|December 6, 2022
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8<sup>+</sup> T cells to overcome immunotherapy resistance in cancerJoonbeom Bae, Longchao Liu, Casey Moore, et al.
The Journal of Clinical Investigation|April 7, 2004
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathyJing Wang, Robert A Anders, Qiang Wu, et al.
Plos One|February 8, 2014
Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironmentJarish N Cohen, Eric F Tewalt, Sherin J Rouhani, et al.
Pageof 34

Showing results (201-210 of 337) with videos related to

Sort By:
Pageof 34
Nature Communications|July 21, 2019
NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistanceXiaoguang Li, Zhida Liu, Anli Zhang, et al.
Nature Immunology|July 31, 2012
OX40 signaling favors the induction of T(H)9 cells and airway inflammationXiang Xiao, Savithri Balasubramanian, Wentao Liu, et al.
Cancer Research|October 22, 2020
RIG-I-Like Receptor LGP2 Is Required for Tumor Control by RadiotherapyWenxin Zheng, Diana Rose E Ranoa, Xiaona Huang, et al.
Science Immunology|May 16, 2025
ILC3s promote intestinal tuft cell hyperplasia and anthelmintic immunity through RANK signalingHongkai Xu, Yibo Wang, Wenyan Wang, et al.
Cancer Cell|July 4, 2020
Telomere Stress Potentiates STING-Dependent Anti-tumor ImmunityIlgen Mender, Anli Zhang, Zhenhua Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastasesPing Yu, Youjin Lee, Yang Wang, et al.
The Journal of Experimental Medicine|March 7, 2020
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signalingYaoyao Shi, Wenxin Zheng, Kaiting Yang, et al.
Nature Cell Biology|December 6, 2022
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8<sup>+</sup> T cells to overcome immunotherapy resistance in cancerJoonbeom Bae, Longchao Liu, Casey Moore, et al.
The Journal of Clinical Investigation|April 7, 2004
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathyJing Wang, Robert A Anders, Qiang Wu, et al.
Plos One|February 8, 2014
Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironmentJarish N Cohen, Eric F Tewalt, Sherin J Rouhani, et al.
Pageof 34